Article
Hypoxia pathway genetic variants predict survival of non-small-cell lung cancer patients receiving platinum-based chemotherapy.
Carcinogenesis - 1 Apr 2017
Li Rong, Gu Jiang, Heymach John V, Shu Xiang, Zhao Lina, Han Baohui, Ye Yuanqing, Roth Jack, Wu Xifeng
Abstract excerpt
Hypoxia is a hallmark of solid tumors and has been implicated in the development of advanced disease and poor clinical outcome. In this multi-stage study, we aimed to assess whether genetic variations in hypoxia pathway genes might affect overall survival (OS) in patients with advanced-stage non-small cell lung cancer (NSCLC). We genotyped 598 potentially functional and tagging single nucleotide polymorphisms...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
